This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy.
和其瑞医药宣布子宫内膜异位症全球临床二期试验中国首例患者开始给药
MORE
和其瑞医药任命陈曦为首席执行官
和其瑞医药宣布首创单抗新药HMI-115获得治疗子宫内膜异位症的 中国临床二期试验批准
Circ Res 北京大学肖瑞平教授团队揭示阻断MG53 S255磷酸化可以保护糖尿病心脏免受缺血性损伤
Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in AGA Alopecia
Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation
Follow Us
Top